TickerFacts.

A business in context

PBYI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-026311

  2. 8-K · Current report

    Report date 2026-08-06 · 0001437749-26-026282 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-07-06 · 0001437749-26-023079

  4. 4 · Ownership change

    Report date 2026-07-06 · 0001437749-26-023078

  5. 4 · Ownership change

    Report date 2026-07-06 · 0001437749-26-023077

  6. 8-K · Current report

    Report date 2026-06-11 · 0001437749-26-020793 · Items 5.07

  7. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020709

  8. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020708

  9. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020706

  10. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020705

  11. 4 · Ownership change

    Report date 2026-06-11 · 0001437749-26-020704

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015633

  13. 8-K · Current report

    Report date 2026-05-07 · 0001437749-26-015621 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001437749-26-013671

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-005891

  16. 8-K · Current report

    Report date 2026-02-26 · 0001437749-26-005869 · Items 2.02,9.01

  17. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-033633

  18. 8-K · Current report

    Report date 2025-11-06 · 0001437749-25-033604 · Items 2.02,9.01

  19. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-025470

  20. 8-K · Current report

    Report date 2025-08-07 · 0001437749-25-025463 · Items 2.02,9.01

  21. 10-Q/A · Quarterly report

    Report date 2025-03-31 · 0001437749-25-025214

  22. 8-K · Current report

    Report date 2025-06-19 · 0001437749-25-021153 · Items 5.03,9.01

  23. 8-K · Current report

    Report date 2025-06-11 · 0001437749-25-020321 · Items 5.07

  24. 8-K · Current report

    Report date 2025-05-08 · 0001437749-25-015648 · Items 5.02

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-015533

  26. 8-K · Current report

    Report date 2025-05-08 · 0001437749-25-015514 · Items 2.02,9.01

  27. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0001437749-25-013337

  28. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-005496

  29. 8-K · Current report

    Report date 2025-02-27 · 0001437749-25-005477 · Items 2.02,9.01

  30. SC 13G · Ownership disclosure

    0002012383-24-004166

  31. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-033955

  32. 8-K · Current report

    Report date 2024-11-07 · 0001437749-24-033929 · Items 2.02,9.01

  33. SC 13G · Ownership disclosure

    0002012383-24-001266

  34. 8-K · Current report

    Report date 2024-09-12 · 0001437749-24-029206 · Items 8.01

  35. 8-K · Current report

    Report date 2024-08-14 · 0001437749-24-026953 · Items 8.01

  36. 8-K · Current report

    Report date 2024-08-06 · 0001437749-24-025027 · Items 8.01

  37. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-024309

  38. 8-K · Current report

    Report date 2024-08-01 · 0001437749-24-024297 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-06-18 · 0001437749-24-021086 · Items 5.02,5.07,9.01

  40. 8-K · Current report

    Report date 2024-05-17 · 0001437749-24-017504 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 7 transaction rows7AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-12
2026-06-15
WILSON TROY EDWARD
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10800.07.2
2026-06-12
2026-06-15
Stuglik Brian M
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8100.07.2
2026-06-12
2026-06-15
Senderowicz Adrian
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock27000.07.2
2026-06-12
2026-06-15
MOYES JAY M
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock22000.07.22
2026-06-12
2026-06-15
Dorval Allison
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11610.07.2
2026-06-11
2026-06-15
WILSON TROY EDWARD
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
Stuglik Brian M
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
Senderowicz Adrian
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
MILLER MICHAEL PATRICKA · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
MOYES JAY M
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
Dorval Allison
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock27000.00.0
2026-06-11
2026-06-15
Cesano AlessandraA · Grant / award
Acquired
Common Stock27000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001401667PUMA BIOTECHNOLOGY, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Puma Biotechnology · alias · wikidata
  • INNOVATIVE ACQUISITIONS CORP · former SEC name · 2007-09-14 to 2011-10-04
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$230.47M$245.32M
2023-12-31$235.64M$258.21M
2022-12-31$228.03M$260.14M
2021-12-31$253.16M$311.91M
2020-12-31$225.11M$290.43M
2019-12-31$272.26M$355.58M
2018-12-31$250.99M$333.75M
2017-12-31$27.68M$37.71M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗